
|Articles|January 16, 2023
DeepIntent Celebrates Year-Over-Year Growth as Marketers Invest in CTV
Advertisement
DeepIntent, a healthcare advertising technology company built to influence better patient health and business outcomes, announced it has reached a significant milestone, achieving growth for the fifth consecutive year and a triple-digit percentage growth rate across connected television (CTV) campaigns.
In 2022, DeepIntent experienced triple-digit growth in CTV investment on its demand side platform, making CTV one of the fastest-growing channels for the hundreds of pharmaceutical brands now using the DeepIntent Healthcare Advertising Platform.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
2
Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D
3
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
4
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
5




